Perspective Therapeutics, Inc. (CATX) › Operating Cash FlowPerspective Therapeutics, Inc. (CATX) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2011: -$2.42M2012: -$2.45M2013: -$3.06M2016: -$3.88M2017: -$5.71M2018: -$5.71M2019: -$5.05M2020: -$3.64M2021: -$2.84M2022: -$10.40M2023: -$36.91M2024: -$18.29M2025: -$82.48M-$82.48M2011Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$82.48M-350.9%2024-$18.29M+50.4%2023-$36.91M-254.9%2022-$10.40M-266.6%2021-$2.84M+22.1%2020-$3.64M+27.9%2019-$5.05M+11.6%2018-$5.71M+0.0%2017-$5.71M-47.1%2016-$3.88M—2013-$3.06M-24.9%2012-$2.45M-1.2%2011-$2.42M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share